Advances in Hematological Malignancies
Recent years have witnessed remarkable progress in the domain of hematological malignancies. Novel therapies such as targeted therapy, immunotherapies, and gene editing are revolutionizing the prognosis for patients with blood cancers. Research studies continue to explore these innovative strategies, offering hope for more curative treatment option